SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,999 | +1.8% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,825 | -1.8% | 10,000 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -50.0% | 10,000 | -50.0% | 0.00% | – |
| Q3 2021 | $20,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,238 | $65,085,000 | 5.22% |
| Opti Capital Management, LP | 9,562 | $8,701,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,486,000 | $6,870,000 | 0.89% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 49,922,000 | $45,350,000 | 0.88% |
| Alken Asset Management Ltd | 500,000 | $455,000 | 0.78% |
| CAMDEN ASSET MANAGEMENT L P /CA | 25,150,000 | $22,765,000 | 0.73% |
| Mohican Financial Management, LLC | 500,000 | $453,000 | 0.71% |
| Lombard Odier Asset Management (Europe) Ltd | 4,650,000 | $4,232,000 | 0.31% |
| M&G INVESTMENT MANAGEMENT LTD | 31,226,000 | $28,416,000 | 0.25% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,838,000 | $12,587,000 | 0.15% |